2025 Q3 -tulosraportti
Vain PDF
48 päivää sitten
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
2 934
Myynti
Määrä
3 822
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 683 | - | - | ||
| 525 | - | - | ||
| 1 432 | - | - | ||
| 1 630 | - | - | ||
| 7 249 | - | - |
Ylin
22,15VWAP
Alin
21,05VaihtoMäärä
10,5 482 251
VWAP
Ylin
22,15Alin
21,05VaihtoMäärä
10,5 482 251
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 492 772 | 492 772 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 492 772 | 492 772 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 27.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 28.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 28.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·22 t sittenSo I have sold my last portion of 15k units at 21,20 and am now out of Saniona after 8 years. I have waited the last 2-3 months for the Tesofensine approval, but I can't be bothered to wait any longer while the price is largely stagnant and I have returns of 20-30-40% on other stocks, primarily American space stocks, in the same period. It has been an exciting journey, especially after a larger purchase around 2 kr to bring my average down after the stock just plunged wildly for a period. Good to see that it came back though and it also resulted in a nice profit even though it took several years 😂 Good luck to all of you who stay in Saniona, I'm quite sure it will give a decent profit over the next few years, but I'm probably a bit more into momentum stocks at the moment. I think the Tesofensine approval will come within a few days now that I have sold 😂
·15 t sittenI have also had it for a very long time and have somewhat reluctantly ended up with a pretty large position and actually just want to get rid of it, but now that something might happen, I have kept my finger right over the sell button without pressing it :)
·4 t sittenWhen it dipped below 2. I was quite annoyed, and fortunately supplemented quite aggressively. And told myself when I'm breakeven I'll sell. But then came the first collaboration, then number 2, as well as the 3 programs they are preparing for phase 1. I'm staying, as I believe it has much more to give. Acadia said at the conference yesterday that they still expect phase 2 on 711 to start in Q4. Then there are 10 million dollars for saniona. As well as we hopefully have jazz in Q2 which gives 7.5 million dollars at the start of phase 1
·9.1.How can 900 units have been traded at 21.67 at 13:05 when it trades in 5 øre intervals?
·9.1.When you trade shares, you can fill the order against multiple levels in the order book. 21,67 can then become an average price. E.g. 540 shares at 21,65 and 360 shares at 21,70 in one trade. I will assume that this is the case here.
·8.1.A Danish company without major individual owners. The largest ownership lies with Avanza and Nordnet. A bit strange, I think.- ·7.1.Copied from Discord exciting 2026 **Triggers we can "count on" in 2026:** - JZP-2355 P1 start Q2 (incl USD 7.5m milestone) - ACP-711 P2 start Q4 (incl USD 10m milestone) - SAN-2219 P1 start - SAN-2668 P1 start **Potential triggers 2026 (not longshots):** - JZP-2355 P1 topline (possibly coming 2027) - Tesofensine outcome Mexico (incl USD 2m milestone if approved) - Strategy for Tesofensine if approved (Brazil etc) - Outcome collaboration with Boerhringer Ingelheim (potential milestone of unknown size if positive outcome) - Outcome collaboration with AstronautX (potential milestone of unknown size if positive outcome) **Uncertain but potential triggers 2026:** - SAN-903 license/spinout - Tesomet license/spinout (depends possibly a bit on how it goes with Tesofensine or Soleno with its VYKATXR as the only approved drug within the PWS sphere, they are struggling a bit at the moment)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
Vain PDF
48 päivää sitten
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·22 t sittenSo I have sold my last portion of 15k units at 21,20 and am now out of Saniona after 8 years. I have waited the last 2-3 months for the Tesofensine approval, but I can't be bothered to wait any longer while the price is largely stagnant and I have returns of 20-30-40% on other stocks, primarily American space stocks, in the same period. It has been an exciting journey, especially after a larger purchase around 2 kr to bring my average down after the stock just plunged wildly for a period. Good to see that it came back though and it also resulted in a nice profit even though it took several years 😂 Good luck to all of you who stay in Saniona, I'm quite sure it will give a decent profit over the next few years, but I'm probably a bit more into momentum stocks at the moment. I think the Tesofensine approval will come within a few days now that I have sold 😂·15 t sittenI have also had it for a very long time and have somewhat reluctantly ended up with a pretty large position and actually just want to get rid of it, but now that something might happen, I have kept my finger right over the sell button without pressing it :)·4 t sittenWhen it dipped below 2. I was quite annoyed, and fortunately supplemented quite aggressively. And told myself when I'm breakeven I'll sell. But then came the first collaboration, then number 2, as well as the 3 programs they are preparing for phase 1. I'm staying, as I believe it has much more to give. Acadia said at the conference yesterday that they still expect phase 2 on 711 to start in Q4. Then there are 10 million dollars for saniona. As well as we hopefully have jazz in Q2 which gives 7.5 million dollars at the start of phase 1
- ·9.1.How can 900 units have been traded at 21.67 at 13:05 when it trades in 5 øre intervals?·9.1.When you trade shares, you can fill the order against multiple levels in the order book. 21,67 can then become an average price. E.g. 540 shares at 21,65 and 360 shares at 21,70 in one trade. I will assume that this is the case here.
- ·8.1.A Danish company without major individual owners. The largest ownership lies with Avanza and Nordnet. A bit strange, I think.
- ·7.1.Copied from Discord exciting 2026 **Triggers we can "count on" in 2026:** - JZP-2355 P1 start Q2 (incl USD 7.5m milestone) - ACP-711 P2 start Q4 (incl USD 10m milestone) - SAN-2219 P1 start - SAN-2668 P1 start **Potential triggers 2026 (not longshots):** - JZP-2355 P1 topline (possibly coming 2027) - Tesofensine outcome Mexico (incl USD 2m milestone if approved) - Strategy for Tesofensine if approved (Brazil etc) - Outcome collaboration with Boerhringer Ingelheim (potential milestone of unknown size if positive outcome) - Outcome collaboration with AstronautX (potential milestone of unknown size if positive outcome) **Uncertain but potential triggers 2026:** - SAN-903 license/spinout - Tesomet license/spinout (depends possibly a bit on how it goes with Tesofensine or Soleno with its VYKATXR as the only approved drug within the PWS sphere, they are struggling a bit at the moment)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
2 934
Myynti
Määrä
3 822
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 683 | - | - | ||
| 525 | - | - | ||
| 1 432 | - | - | ||
| 1 630 | - | - | ||
| 7 249 | - | - |
Ylin
22,15VWAP
Alin
21,05VaihtoMäärä
10,5 482 251
VWAP
Ylin
22,15Alin
21,05VaihtoMäärä
10,5 482 251
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 492 772 | 492 772 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 492 772 | 492 772 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 27.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 28.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 28.11.2024 |
2025 Q3 -tulosraportti
Vain PDF
48 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 27.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 28.5.2025 | |
| 2024 Q4 -tulosraportti | 27.2.2025 | |
| 2024 Q3 -tulosraportti | 28.11.2024 |
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·22 t sittenSo I have sold my last portion of 15k units at 21,20 and am now out of Saniona after 8 years. I have waited the last 2-3 months for the Tesofensine approval, but I can't be bothered to wait any longer while the price is largely stagnant and I have returns of 20-30-40% on other stocks, primarily American space stocks, in the same period. It has been an exciting journey, especially after a larger purchase around 2 kr to bring my average down after the stock just plunged wildly for a period. Good to see that it came back though and it also resulted in a nice profit even though it took several years 😂 Good luck to all of you who stay in Saniona, I'm quite sure it will give a decent profit over the next few years, but I'm probably a bit more into momentum stocks at the moment. I think the Tesofensine approval will come within a few days now that I have sold 😂·15 t sittenI have also had it for a very long time and have somewhat reluctantly ended up with a pretty large position and actually just want to get rid of it, but now that something might happen, I have kept my finger right over the sell button without pressing it :)·4 t sittenWhen it dipped below 2. I was quite annoyed, and fortunately supplemented quite aggressively. And told myself when I'm breakeven I'll sell. But then came the first collaboration, then number 2, as well as the 3 programs they are preparing for phase 1. I'm staying, as I believe it has much more to give. Acadia said at the conference yesterday that they still expect phase 2 on 711 to start in Q4. Then there are 10 million dollars for saniona. As well as we hopefully have jazz in Q2 which gives 7.5 million dollars at the start of phase 1
- ·9.1.How can 900 units have been traded at 21.67 at 13:05 when it trades in 5 øre intervals?·9.1.When you trade shares, you can fill the order against multiple levels in the order book. 21,67 can then become an average price. E.g. 540 shares at 21,65 and 360 shares at 21,70 in one trade. I will assume that this is the case here.
- ·8.1.A Danish company without major individual owners. The largest ownership lies with Avanza and Nordnet. A bit strange, I think.
- ·7.1.Copied from Discord exciting 2026 **Triggers we can "count on" in 2026:** - JZP-2355 P1 start Q2 (incl USD 7.5m milestone) - ACP-711 P2 start Q4 (incl USD 10m milestone) - SAN-2219 P1 start - SAN-2668 P1 start **Potential triggers 2026 (not longshots):** - JZP-2355 P1 topline (possibly coming 2027) - Tesofensine outcome Mexico (incl USD 2m milestone if approved) - Strategy for Tesofensine if approved (Brazil etc) - Outcome collaboration with Boerhringer Ingelheim (potential milestone of unknown size if positive outcome) - Outcome collaboration with AstronautX (potential milestone of unknown size if positive outcome) **Uncertain but potential triggers 2026:** - SAN-903 license/spinout - Tesomet license/spinout (depends possibly a bit on how it goes with Tesofensine or Soleno with its VYKATXR as the only approved drug within the PWS sphere, they are struggling a bit at the moment)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
2 934
Myynti
Määrä
3 822
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 683 | - | - | ||
| 525 | - | - | ||
| 1 432 | - | - | ||
| 1 630 | - | - | ||
| 7 249 | - | - |
Ylin
22,15VWAP
Alin
21,05VaihtoMäärä
10,5 482 251
VWAP
Ylin
22,15Alin
21,05VaihtoMäärä
10,5 482 251
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 492 772 | 492 772 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 492 772 | 492 772 | 0 | 0 |